LINDSAY PHILLIPS: Open Payments
NPI 1225872377 · MUSKOGEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 29 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $506 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $145 |
| Alpha Cognition USA, Inc. | 1 | $121 |
| PFIZER INC. | 4 | $81 |
| Novo Nordisk Inc | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
Products named: Qelbree, Zunveyl, PREVNAR 20, JARDIANCE, Ozempic, Kerendia, SPRAVATO, Auvelity.
Industry payments across OK — which companies pay providers there.
